Mentor Capital Selects Colorado Auditor for the Next Phase of Its Medical Marijuana and Cannabis Business
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has engaged BF Borgers CPA PC as its new public accounting firm and has filed a Form 8-K with the SEC through the EDGAR system detailing this move to the Colorado based auditor. Mentor CEO Chet Billingsley observes, “Given our ongoing medical marijuana and cannabis focus, it made sense to move to an auditor in a state where many cannabis businesses are active and marijuana has been legalized at the state level. This further supports our earlier 2014 actions to progressively step up our reporting levels from limited information, to current information, and with the recent completion of two years of financial audits and an initial Form 10 filing, toward being fully reporting with the SEC.”
The Form 8-K, which indicates that there were no disagreements with the previous auditor, Albert Wong & Co. of New York and Hong Kong, nor any reportable events, can be referenced through the SEC’s EDGAR system at:
Inputting the company name, Mentor Capital, Inc. or the company’s CIK code which is 0001599117, will bring up the report. The Form 8-K will also be able to be viewed at the company’s web site: www.MentorCapital.com at the Investor’s Corner section under the Disclosures tab.
About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at the company website above.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here:
The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Chet Billingsley, CEO